Addresses

From Institute of Cardiovascular Science, University College London, UK (A.A.-G., S.N., E.A.A., M.F., C.M., J.M.W., J.C.M.);Barts Heart Centre, London, UK (A.A.-G., S.N., E.A.A., C.M., M.W., J.C.M.); Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Y.V., M.T., P.S., N.U.); King Chulalongkorn Memorial Hospital, Bangkok, Thailand (Y.V., M.T., P.S., N.U.); Queen Savang Vadhana Memorial Hospital, Sriracha, Thailand (H.N.); Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, Bethesda, MD (P.K.); University of Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Department of Medicine, Division of Cardiovascular Medicine, UK (S.K.P.); National Amyloidosis Centre, Royal Free Hospital, London, UK (M.F.); Cardiovascular Imaging Center, Jose Michel Kalaf Research Institute, Sao Paulo, Brazil (J.L.F.); Haematology Department, University College London Hospitals, UK (J.B.P.); and Hatter Cardiovascular Institute, University College Hospital, London, UK (J.M.W.). a.abdel-gadir@ucl.ac.uk.